Aljian Capital Management LLC bought a new stake in shares of Danaher Co. (NYSE:DHR – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,344 shares of the conglomerate’s stock, valued at approximately $652,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. nVerses Capital LLC purchased a new position in shares of Danaher in the 2nd quarter valued at approximately $25,000. CarsonAllaria Wealth Management Ltd. purchased a new position in shares of Danaher in the 2nd quarter worth $25,000. MFA Wealth Advisors LLC bought a new stake in shares of Danaher during the 2nd quarter valued at about $51,000. Financial Connections Group Inc. purchased a new stake in Danaher during the second quarter valued at approximately $51,000. Finally, Western Pacific Wealth Management LP purchased a new stake in shares of Danaher in the 1st quarter worth $55,000. Institutional investors own 79.05% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the stock. Stifel Nicolaus increased their target price on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Royal Bank of Canada reduced their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research report on Thursday, October 31st. TD Cowen boosted their price target on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Finally, Robert W. Baird lowered their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.
Insiders Place Their Bets
In related news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. This trade represents a 18.44 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 11.10% of the stock is currently owned by company insiders.
Danaher Stock Performance
Shares of DHR stock opened at $230.50 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a 1 year low of $206.30 and a 1 year high of $281.70. The firm has a market capitalization of $166.48 billion, a price-to-earnings ratio of 43.99, a price-to-earnings-growth ratio of 4.24 and a beta of 0.85. The business has a fifty day moving average of $262.20 and a 200 day moving average of $260.57.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the firm posted $2.02 earnings per share. As a group, research analysts expect that Danaher Co. will post 7.51 earnings per share for the current year.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- With Risk Tolerance, One Size Does Not Fit All
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Profitably Trade Stocks at 52-Week Highs
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How to Invest in the FAANG Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.